Fidelity of Target Site Duplication and Sequence Preference during Integration of Xenotropic Murine Leukemia Virus-Related Virus

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Kim, Sanggu ^a   Rusmevichientong, Alice ^b   Dong, Beihua ^c   Remenyi, Roland ^b   Silverman, Robert H ^c   Chow, Samson A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GUANINE; VIRUS DNA;

ARTICLE; CELL EXPANSION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA INTEGRATION; DNA SEQUENCE; GENE DUPLICATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROVIRUS; RETROVIRUS; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; CELL LINE; CHRONIC FATIGUE SYNDROME; FEMALE; GENETICS; MALE; MURINE LEUKEMIA VIRUS; PROSTATE TUMOR; RETROVIRUS INFECTION; VIROLOGY; VIRUS INFECTION;

XENOTROPIC MURINE LEUKEMIA VIRUS;

CELL LINE; DNA, VIRAL; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; LEUKEMIA VIRUS, MURINE; MALE; PROSTATIC NEOPLASMS; RETROVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 77954539634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010255     Document Type: Article

References (61)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
2. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42: 1805-1812.
3. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, et al. (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32: 581-583.
4. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, et al. (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 29,59-oligoadenylates. Cancer Res 63: 6795-6801.
5. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 104: 1655-1660.
6. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 106: 16351-16356.
7. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
8. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6: 92.
9. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 5: e8519.
10. Groom H, Boucherit V, Makinson K, Randal E, Baptista S, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
11. van Kuppeveld FJM, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJG, et al. (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 340: c1018.
12. Brown PO (1997) Integration. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. pp 161-203.
13. Mikkers H, Berns A (2003) Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res 88: 53-99.
14. Kim S, Kim N, Dong B, Boren D, Lee SA, et al. (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82: 9964-9977.
15. Yoder KE, Bushman FD (2000) Repair of gaps in retroviral DNA integration intermediates. J Virol 74: 11191-11200.
16. Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, et al. (2001) Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. Embo J 20: 3272-3281.
17. Muesing MA, Smith DH, Cabradilla CD, Benson CV, Lasky LA, et al. (1985) Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 313: 450-458.
18. Vincent KA, York HD, Quiroga M, Brown PO (1990) Host sequences flanking the HIV provirus. Nucleic Acids Res 18: 6045-6047.
19. Vink C, Groenink M, Elgersma Y, Fouchier RA, Tersmette M, et al. (1990) Analysis of the junctions between human immunodeficiency virus type 1 proviral DNA and human DNA. J Virol 64: 5626-5627.
20. Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, et al. (1980) Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci USA 77: 3932-3936.
21. Shoemaker C, Hoffman J, Goff SP, Baltimore D (1981) Intramolecular integration within Moloney murine leukemia virus. J Virol 40: 164-172.
22. Horowitz JM, Holland GD, King SR, Risser R (1987) Germ line integration of a murine leukemia provirus into a retroviruslike sequence. J Virol 61: 701-707.
23. Shimotohno K, Temin HM (1980) No apparent nucleotide sequence specificity in cellular DNA juxtaposed to retrovirus proviruses. Proc Natl Acad Sci USA 77: 7357-7361.
24. Shimotohno K, Mizutani S, Temin HM (1980) Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature 285: 550-554.
25. Moreau K, Torne-Celer C, Faure C, Verdier G, Ronfort C (2000) In vivo retroviral integration: fidelity to size of the host DNA duplication might be reduced when integration occurs near sequences homologous to LTR ends. Virology 278: 133-136.
26. Taganov K, Daniel R, Katz RA, Favorova O, Skalka AM (2001) Characterization of retrovirus-host DNA junctions in cells deficient in nonhomologous-end joining. J Virol 75: 9549-9552.
27. Oh J, Chang KW, Alvord WG, Hughes SH (2006) Alternate polypurine tracts affect Rous sarcoma virus integration in vivo. J Virol 80: 10281-10284.
28. Oh J, Chang KW, Hughes SH (2006) Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by Rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J Virol 80: 451-459.
29. Vatakis DN, Kim S, Kim N, Chow SA, Zack JA (2009) Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. J Virol 83: 6222-6533.
30. Aiyar A, Hindmarsh P, Skalka AM, Leis J (1996) Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol 70: 3571-3580.
31. Goodarzi G, Pursley M, Felock P, Witmer M, Hazuda D, et al. (1999) Efficiency and fidelity of full-site integration reactions using recombinant simian immunodeficiency virus integrase. J Virol 73: 8104-8111.
32. Hindmarsh P, Ridky T, Reeves R, Andrake M, Skalka AM, et al. (1999) HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol 73: 2994-3003.
33. Li M, Craigie R (2005) Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J Biol Chem 280: 29334-29339.
34. Holman AG, Coffin JM (2005) Symmetrical base preferences surrounding HIV- 1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci USA 102: 6103-6107.
35. Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, et al. (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79: 6610-6619.
36. Berry C, Hannenhalli S, Leipzig J, Bushman FD (2006) Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2: e157.
37. Kim S, Kim Y, Liang T, Sinsheimer JS, Chow SA (2006) A high-throughput method for cloning and sequencing HIV-1 integration sites. J Virol 80: 11313-11321.
38. Derse D, Crise B, Li Y, Princler G, Lum N, et al. (2007) Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol 81: 6731-6741.
39. Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, et al. (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2: 611-622.
40. Murphy JE, Goff SP (1992) A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J Virol 66: 5092-5095.
41. Moreau K, Faure C, Violot S, Gouet P, Verdier G, et al. (2004) Mutational analyses of the core domain of avian leukemia and sarcoma viruses integrase: critical residues for concerted integration and multimerization. Virology 318: 566-581.
42. Li M, Mizuuchi M, Burke TR, Jr., Craigie R (2006) Retroviral DNA integration: reaction pathway and critical intermediates. Embo J 25: 1295-1304.
43. Sinha S, Pursley MH, Grandgenett DP (2002) Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J Virol 76: 3105-3113.
44. Craigie R (1992) Hotspots and warm spots: integration specificity of retroelements. Trends Genet 8: 187-190.
45. Withers-Ward ES, Kitamura Y, Barnes JP, Coffin JM (1994) Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev 8: 1473-1487.
46. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
47. Holmes-Son ML, Appa RS, Chow SA (2001) Molecular genetics and target site specificity of retroviral integration. Adv Genet 43: 33-69.
48. Bushman F, Lewinski M, Ciuffi A, Barr S, Leipzig J, et al. (2005) Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 3: 848-858.
49. Pryciak PM, Varmus HE (1992) Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69: 769-780.
50. Katzman M, Sudol M (1995) Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases. J Virol 69: 5687-5696.
51. Shibagaki Y, Chow SA (1997) Central core domain of retroviral integrase is responsible for target site selection. J Biol Chem 272: 8361-8369.
52. Hacker CV, Vink CA, Wardell TW, Lee S, Treasure P, et al. (2006) The integration profile of EIAV-based vectors. Mol Ther 14: 536-545.
53. Kang Y, Moressi CJ, Scheetz TE, Xie L, Tran DT, et al. (2006) Integration site choice of a feline immunodeficiency virus vector. J Virol 80: 8820-8823.
54. Moalic Y, Blanchard Y, Felix H, Jestin A (2006) Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J Virol 80: 10980-10988.
55. Nowrouzi A, Dittrich M, Klanke C, Heinkelein M, Rammling M, et al. (2006) Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol 87: 1339-1347.
56. Muller HP, Varmus HE (1994) DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J 13: 4704-4714.
57. Taganov KD, Cuesta I, Daniel R, Cirillo LA, Katz RA, et al. (2004) Integrasespecific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro. J Virol 78: 5848-5855.
58. Bor Y-C, Bushman FD, Orgel L (1995) In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc Natl Acad Sci USA 92: 10334-10338.
59. Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD (2007) HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17: 1186-1194.
60. Rosenberg N, Jolicoeur P (1997) Retroviral pathogenesis. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. pp 475-586.
61. Gabriel R, Eckenberg R, Paruzynski A, Bartholomae CC, Nowrouzi A, et al. (2009) Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 15: 1431-1436.